New Oxford research institute established to tackle antimicrobial resistance
A new research institute at the University of Oxford has been established to fight against antimicrobial resistance (AMR).
The Ineos Oxford Institute (IOI) will be based between two sites in Oxford, linking the university’s Department of Chemistry and the Department of Zoology.
It will build on Oxford’s expertise and legacy in the field of AMR and antibiotic research and drug discovery – scientists at the university made progress in making concentrated penicillin after it was discovered by Alexander Fleming in the early 20th century.
The new institute has initially received funding from Ineos, a British chemical company, totalling £100m, which will enable research into the development of new drugs tackling AMR for animals and humans.
The institute will also aim to spread awareness of the responsible use of existing antibiotic medications. The IOI plans to partner with other global leaders in AMR research to achieve this goal.
Read more: http://www.pmlive.com/pharma_news/new_oxford_research_institute_established_to_tackle_antimicrobial_resistance_1361614
The Ineos Oxford Institute (IOI) will be based between two sites in Oxford, linking the university’s Department of Chemistry and the Department of Zoology.
It will build on Oxford’s expertise and legacy in the field of AMR and antibiotic research and drug discovery – scientists at the university made progress in making concentrated penicillin after it was discovered by Alexander Fleming in the early 20th century.
The new institute has initially received funding from Ineos, a British chemical company, totalling £100m, which will enable research into the development of new drugs tackling AMR for animals and humans.
The institute will also aim to spread awareness of the responsible use of existing antibiotic medications. The IOI plans to partner with other global leaders in AMR research to achieve this goal.
Read more: http://www.pmlive.com/pharma_news/new_oxford_research_institute_established_to_tackle_antimicrobial_resistance_1361614
